PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA
Mohiedeen, K., Kasem, M., Abdeen Ahmed, N., Zaghloul Taleb, R., Silas, M. (2024). PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA. EKB Journal Management System, 6(2), 25-26. doi: 10.21608/alexpo.2024.290679.1846
Khalid Mahmoud Mohiedeen; Mohamed Ahmed Kasem; Nermeen Sherif Abdeen Ahmed; Raghda Saad Zaghloul Taleb; Mariam Abubakar Silas. "PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA". EKB Journal Management System, 6, 2, 2024, 25-26. doi: 10.21608/alexpo.2024.290679.1846
Mohiedeen, K., Kasem, M., Abdeen Ahmed, N., Zaghloul Taleb, R., Silas, M. (2024). 'PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA', EKB Journal Management System, 6(2), pp. 25-26. doi: 10.21608/alexpo.2024.290679.1846
Mohiedeen, K., Kasem, M., Abdeen Ahmed, N., Zaghloul Taleb, R., Silas, M. PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA. EKB Journal Management System, 2024; 6(2): 25-26. doi: 10.21608/alexpo.2024.290679.1846

PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA

ALEXMED ePosters
Article 1, Volume 6, Issue 2, April 2024, Page 25-26  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.290679.1846
View on SCiNiTO View on SCiNiTO
Authors
Khalid Mahmoud Mohiedeen1; Mohamed Ahmed Kasem1; Nermeen Sherif Abdeen Ahmed1; Raghda Saad Zaghloul Taleb2; Mariam Abubakar Silas email 1
1Department of Tropical Medicine, Faculty of Medicine, Alexandria University
2Department of Clinical & chemical Patholohy**, Faculty of Medicine, Alexandria University, Egypt
Abstract
INTRODUCTION

Viral hepatitis, including Hepatitis B and C, is a significant global health challenge and a leading cause of mortality. In Egypt, approximately eight to ten million people are affected by these viruses, posing a serious public health threat. Chronic viral hepatitis can lead to severe complications, with cirrhosis often emerging after prolonged infection, increasing the risk of advanced liver diseases like hepatocellular carcinoma (HCC). Early detection of HCC is crucial, and current guidelines recommend biannual abdominal ultrasound and AFP testing for at-risk patients, though this method has limitations, including a sensitivity of only 63%.Identifying accurate biomarkers for HCC diagnosis is a priority. Glypican-3 (GPC3) and Golgi Protein 73 (GP73) have shown promise as potential biomarkers. GPC3 is highly expressed in HCC tumors and detectable in serum, while GP73 has demonstrated superior sensitivity to AFP. Despite their potential, further validation is necessary.

AIM
The present study aims to assess the serum level of GP73 and GPC-3 as diagnostic biomarkers for HCC in patients with viral hepatitis B and C liver cirrhosis.
Keywords
GOLGI PROTEIN-73; GLYPICAN-3; HEPATOCELLULAR CARCINOMA
Supplementary Files
Statistics
Article View: 75